Core Viewpoint - China Life Insurance (02628.HK) has shown strong technical performance, breaking out of a previous sluggish phase and establishing a mid-term upward trend, with significant trading volume indicating increased investment in the financial insurance sector [1][3]. Technical Analysis - The stock price has surpassed key resistance levels of 16.00 to 16.14 HKD and is approaching a short-term resistance level of 17.10 HKD. A solid hold above this level could pave the way for challenges to previous highs of 19 HKD and even 20.50 HKD [3]. - The technical structure displays a typical W-bottom rebound, supported by ideal trading volume, indicating market consensus on the rebound and suggesting the potential for a new mid-term upward trend [3]. - Technical indicators such as the MACD show a bullish momentum with a golden cross and increasing histogram, while the RSI is above 70, indicating overbought conditions but without clear signs of weakness [3][6]. Market Signals - Currently, the market has set a short-term target price for China Life at 18.42 HKD, suggesting approximately 2.91% upside potential, with mid-term potential to challenge above 20 HKD [6]. - The market sentiment remains highly bullish, with 16 strong buy signals identified, reflecting a strong technical buying consensus [6]. Investment Strategy - Investors are advised to monitor the consolidation platform between 16.10 and 16.30 HKD. If the stock price maintains stability and breaks above 17.20 HKD with increased volume, it will confirm the breakout, allowing for incremental buying with targets set between 19 and 20.50 HKD [9].